Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39026 - 39050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Enzacamene	Approved	TGOLN2	10618	upregulated	enzacamene results in increased expression of TGOLN2 mRNA	2p11.2	A20648
Enzacamene	Approved	ZNF676	163223	downregulated	enzacamene results in decreased expression of ZNF676 mRNA	19p12	A20648
Ephedrine	Approved Investigational	FOS	2353	upregulated	Ephedrine results in increased expression of FOS mRNA	14q24.3	A20417
Epirubicin	Approved Investigational	ABCB1	5243	upregulated	Epirubicin analog results in increased expression of ABCB1 mRNA	7q21.12	A22513
Epirubicin	Approved Investigational	ABCB1	5243	upregulated	Epirubicin results in increased expression of ABCB1 mRNA	7q21.12	A22514 A22515 A22513
Epirubicin	Approved Investigational	ABCC1	4363	upregulated	Epirubicin analog results in increased expression of ABCC1 mRNA	16p13.11	A22513
Epirubicin	Approved Investigational	ABCC1	4363	upregulated	Epirubicin results in increased expression of ABCC1 mRNA	16p13.11	A22514 A22515 A22513
Epirubicin	Approved Investigational	ABCC2	1244	upregulated	Epirubicin analog results in increased expression of ABCC2 mRNA	10q24.2	A22513
Epirubicin	Approved Investigational	ABCC2	1244	upregulated	Epirubicin results in increased expression of ABCC2 mRNA	10q24.2	A22514 A22515 A22513
Epirubicin	Approved Investigational	BAX	581	upregulated	Epirubicin results in increased expression of BAX mRNA	19q13.33	A22514 A22515 A22513
Epirubicin	Approved Investigational	BCL2	596	upregulated	Epirubicin analog results in increased expression of BCL2 mRNA	18q21.33	A22513
Epirubicin	Approved Investigational	BCL2	596	upregulated	Epirubicin results in increased expression of BCL2 mRNA	18q21.33	A21866 A22515
Epirubicin	Approved Investigational	CASP3	836	upregulated	Epirubicin results in increased expression of CASP3 mRNA	4q35.1	A21866 A22514 A22515 A22513
Epirubicin	Approved Investigational	CASP9	842	upregulated	Epirubicin results in increased expression of CASP9 mRNA	1p36.21	A22514 A22515 A22513
Epirubicin	Approved Investigational	FKBPL	63943	upregulated	Epirubicin results in increased expression of FKBPL mRNA	6p21.32	A21866
Epirubicin	Approved Investigational	MIR302B	442894	upregulated	Epirubicin results in increased expression of MIR302B mRNA	4q25	A22516
Epirubicin	Approved Investigational	TP53	7157	upregulated	Epirubicin results in increased expression of TP53 mRNA	17p13.1	A22514 A22513
Epigallocatechin gallate	Investigational	ABCA1	19	upregulated	epigallocatechin gallate results in increased expression of ABCA1 mRNA	9q31.1	A22517
Epigallocatechin gallate	Investigational	ABCB1	5243	downregulated	epigallocatechin gallate results in decreased expression of ABCB1 mRNA	7q21.12	A22518
Epigallocatechin gallate	Investigational	ABCB10	23456	upregulated	epigallocatechin gallate results in increased expression of ABCB10 mRNA	1q42.13	A22518
Epigallocatechin gallate	Investigational	ABCB11	8647	upregulated	epigallocatechin gallate results in increased expression of ABCB11 mRNA	2q31.1	A21589
Epigallocatechin gallate	Investigational	ABCG1	9619	downregulated	epigallocatechin gallate results in decreased expression of ABCG1 mRNA	21q22.3	A20441
Epigallocatechin gallate	Investigational	ABCG2	9429	upregulated	epigallocatechin gallate results in increased expression of ABCG2 mRNA	4q22.1	A22518
Epigallocatechin gallate	Investigational	ACLY	47	upregulated	epigallocatechin gallate results in increased expression of ACLY mRNA	17q21.2	A21627
Epigallocatechin gallate	Investigational	ADAMTS15	170689	upregulated	epigallocatechin gallate results in increased expression of ADAMTS15 mRNA	11q24.3	A22519

Displaying entries 39026 - 39050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability